Chronic diarrhea differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 26: Line 26:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
|
* [[Abdominal pain]] followed by diarrhea
* [[Abdominal pain]] followed by [[diarrhea]]
|
|
* [[Abdominal]] [[tenderness ]]when palpated in severe disease
* [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]]
* Blood seen on [[rectal exam]]
* Blood seen on [[rectal exam]]
*[[Fever]]
*[[Fever]]
Line 36: Line 36:
* [[Colonoscopy]] with [[biopsy]]
* [[Colonoscopy]] with [[biopsy]]
|
|
* Topical mucosamine and [[corticosteroids]] are prefferd
* Topical mucosamine and [[corticosteroids]] are preferred
* [[Mesalamine]] and [[sulfasalazine]] are used for remission
* [[Mesalamine]] and [[sulfasalazine]] are used for remission
|-
|-
Line 52: Line 52:
* Increased DTR
* Increased DTR
|
|
* TSH with T3 and T4
* [[TSH]] with [[T3]] and [[T4]]
|
|
* [[Carbimazole]]  and [[methimazole]]  
* [[Carbimazole]]  and [[methimazole]]  
Line 58: Line 58:
* [[Iodine-131]]
* [[Iodine-131]]
|-
|-
|VIPoma
|[[VIPoma]]
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| -
| -
Line 77: Line 77:
* [[Abdominal tenderness]] in the right upper abdominal quadrant
* [[Abdominal tenderness]] in the right upper abdominal quadrant
|
|
* Elevated VIP levels
* Elevated [[VIP]] levels
* Followed by imaging
* Followed by imaging
|
|
* [[Sandostatin]] or [[chemotherapy]]  for malignant tumors
* [[Sandostatin]] or [[chemotherapy]]  for [[malignant tumors]]
* Surgical removal of the [[tumor]]
* Surgical removal of the [[tumor]]
|-
|-
| rowspan="2" |Osmotic
| rowspan="2" |[[Osmotic]]
|Lactose intolerance
|[[Lactose intolerance]]
| -
| -
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 100: Line 100:
* Substitution to maintain nutrient intake
* Substitution to maintain nutrient intake
* Regulation of [[calcium]] intake
* Regulation of [[calcium]] intake
* Use of enzyme [[lactase]]
* Use of [[enzyme]] [[lactase]]
|-
|-
|[[Celiac disease (patient information)|Celiac disease]]
|[[Celiac disease (patient information)|Celiac disease]]
Line 118: Line 118:
* [[Mouth ulcers]]
* [[Mouth ulcers]]
* [[Dermatitis herpetiformis]]
* [[Dermatitis herpetiformis]]
* Signs of the fat-soluble vitamins A, D, E, and K deficiency
* Signs of the fat-soluble [[Vitamin A|vitamins A]], D, E, and K deficiency
|
|
* IgA tissue transglutaminase Ab
* [[IgA]] tissue [[transglutaminase]] Ab
|
|
* [[Gluten-free diet]]
* [[Gluten-free diet]]
Line 126: Line 126:
|
|
|Functional
|Functional
|Irritable bowel syndrome
|[[Irritable bowel syndrome]]
| -
| -
| -
| -
Line 137: Line 137:
* Onset associated with change in appearance of stool
* Onset associated with change in appearance of stool


* 25% of bowel movements are loose stools
* 25% of [[Bowel movement|bowel movements]] are loose stools
History of straining is also common
History of straining is also common
|
|
Line 143: Line 143:
* Hard stool in the rectal vault
* Hard stool in the rectal vault
|
|
* Clinical diagnosis
* [[Diagnosis|Clinical diagnosis]]
** ROME III criteria
** ROME III criteria
** Pharmacologic studies based criteria
** [[Pharmacological|Pharmacologic]] studies based criteria
|
|
* High [[dietary fiber]]
* High [[dietary fiber]]
* Osmotic [[laxatives]] such as [[polyethylene glycol]], [[sorbitol]], and [[lactulose]]
* [[Osmotic]] [[laxatives]] such as [[polyethylene glycol]], [[sorbitol]], and [[lactulose]]
* [[Antispasmodic]] drugs (e.g. [[Anticholinergic|anticholinergics]] such as [[hyoscyamine]] or [[dicyclomine]])
* [[Antispasmodic]] drugs (e.g. [[Anticholinergic|anticholinergics]] such as [[hyoscyamine]] or [[dicyclomine]])
|}{{WikiDoc Help Menu}} {{WikiDoc Sources}}
|}{{WikiDoc Help Menu}} {{WikiDoc Sources}}
Line 174: Line 174:
| +
| +
|
|
* Bloating,
* [[Bloating|Bloating,]]
* Flatulence
* [[Flatulence]]
* Abdominal pain, and/or chronic diarrhea  
* [[Abdominal pain]], and/or [[chronic diarrhea]]
* after ingestion of lactose
* after ingestion of [[lactose]]
|
|
* [[Abdominal]] [[tenderness ]]when palpated in severe disease
* [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]]
* Fever
* [[Fever]]
* Hypotension
* [[Hypotension]]
* Tachycardia
* [[Tachycardia]]
* Nausea and vomitting
* [[Nausea and vomiting]]
|Lactose breath hydrogen test
|[[Hydrogen Breath Test|Lactose breath hydrogen test]]
|Restriction of  lactose and  maintain calcium and vitamin D intake.
|Restriction of  [[lactose]] and  maintain [[calcium]] and [[vitamin D]] intake.
|-
|-
|[[Celiac sprue]]
|[[Celiac sprue]]
Line 191: Line 191:
| +
| +
|
|
* Diarrhea with bulky, foul-smelling stools
* [[Diarrhea]] with bulky, [[Steatorrhea|foul-smelling stools]]
* Growth failure in children,  
* [[Growth failure]] in children,  
* Weight loss,  
* [[Weight loss|Weight loss,]]
* Anemia,  
* [[Anemia]],  
* Neurologic disorders
* [[Neurologic diseases|Neurologic disorders]]
* Osteopenia
* [[Osteopenia]]
|
|
* Neuropsychiatric disease
* [[Neuropsychiatric|Neuropsychiatric disease]]
* Dermatitis herpetiformis
* [[Dermatitis herpetiformis]]
* Arthritis
* [[Arthritis]]
* Iron deficiency
* [[Iron deficiency]]
* Metabolic bone disease
* [[Metabolic]] bone disease
* Hyposplenism  
* [[Hyposplenism]]
* Kidney disease
* [[Kidney disease]]
* Idiopathic pulmonary hemosiderosis
* [[Idiopathic pulmonary hemosiderosis]]
|Immunoglobulin A (IgA) anti-tissue transglutaminase (TTG) antibody followed by upper ebdoscopy with biopsy.
|[[Immunoglobulin A]] ([[IgA]]) [[Tissue transglutaminase|anti-tissue transglutaminase]] (TTG) antibody followed by upper [[endoscopy]] with [[biopsy]].
|Dietary counseling, elimination of gluten in the diet.
|Dietary counseling, elimination of [[gluten]] in the diet.
|-
|-
|[[Whipple's disease|Whipple disease]]
|[[Whipple's disease|Whipple disease]]
Line 213: Line 213:
| +
| +
|
|
* Arthralgias
* [[Arthralgias]]
* Weight loss
* [[Weight loss]]
* Diarrhea
* [[Diarrhea]]
* Abdominal pain
* [[Abdominal pain]]
|
|
* Leukocytopenia
* [[Leukocytopenia]]
* Thrombocytopenia
* [[Thrombocytopenia]]
* Skin hyperpigmentation
* [[Skin hyperpigmentation]]
*
|Upper [[endoscopy]] with [[biopsies]] of the [[small intestine]] for ''[[Tropheryma whipplei|T. whipplei]]'' testing ([[histology]] with [[Periodic acid-Schiff stain|PAS staining]], [[polymerase chain reaction]] [[[PCR]]] testing, and [[immunohistochemistry]])
|Upper endoscopy with biopsies of the small intestine for ''T. whipplei'' testing (histology with PAS staining, polymerase chain reaction [PCR] testing, and immunohistochemistry)
|[[Doxycycline]] and [[hydroxychloroquine]] are [[bactericidal]]
|Doxycycline and hydroxychloroquine was bactericidal
|}
|}
'''The table below summarizes the findings that differentiate inflammatory causes of chronic diarrhea'''
'''The table below summarizes the findings that differentiate inflammatory causes of chronic diarrhea'''
Line 233: Line 232:
!Treatment  
!Treatment  
|-
|-
|Diverticulitis
|[[Diverticulitis]]
|
|
* Bloody diarrhea
* [[Bloody diarrhea]]
* Left lower quadrant abdominal pain  
* Left lower quadrant [[abdominal pain]]
* Abdominal tenderness on physical examination
* [[Abdominal tenderness]] on [[physical examination]]
* Low grade fever
* Low grade [[fever]]
|
|
* Leukocytosis
* [[Leukocytosis]]
* Elevated serum amylase and lipase
* Elevated serum [[amylase]] and [[lipase]]
* Sterile pyuria on urinalysis
* [[Sterile]] [[pyuria]] on [[urinalysis]]
|Abdominal CT scan with oral and intravenous (IV) contrast
|Abdominal [[CT scan]] with oral and intravenous [[Contrast medium|(IV) contrast]]
|bowel rest, IV fluid resuscitation, and broad-spectrum antimicrobial therapy which covers [[Anaerobic organism|anaerobic]] [[bacteria]] and [[gram-negative]] [[Bacteria|rods]]
|bowel rest, [[Intravenous fluids|IV fluid]] resuscitation, and [[Broad-spectrum antibiotic|broad-spectrum antimicrobial therapy]] which covers [[Anaerobic organism|anaerobic]] [[bacteria]] and [[gram-negative]] [[Bacteria|rods]]
|-
|-
|Ulcerative colitis
|[[Ulcerative colitis]]
|
|
* [[Diarrhea]] mixed with blood and [[mucus]], of gradual onset.
* [[Diarrhea]] mixed with blood and [[mucus]], of gradual onset.
* Signs of [[weight loss]]
* Signs of [[weight loss]]
* Rectal urgency
* [[Rectal pain|Rectal urgency]]
* [[Tenesmus]]
* [[Tenesmus]]
* Blood is often noticed on underwear
* [[Blood]] is often noticed on underwear
* Different degrees of [[abdominal pain]]
* Different degrees of [[abdominal pain]]
|
|
Line 259: Line 258:
* A high [[platelet]] count
* A high [[platelet]] count


* Elvated ESR (>30mm/hr)
* Elevated [[ESR]] (>30mm/hr)
* Low albumin
* Low [[albumin]]
|[[Endoscopy]]
|[[Endoscopy]]
|Induction of  [[Remission (medicine)|remission]] with mesalamine and corticosteroids followed by the administration of sulfasalazine and 6-Mercaptopurine depending on the severity of the disease. See ...
|Induction of  [[Remission (medicine)|remission]] with [[mesalamine]] and [[corticosteroids]] followed by the administration of [[sulfasalazine]] and [[Mercaptopurine|6-Mercaptopurine]] depending on the severity of the [[disease]].  
|-
|-
|Entamoeba histolytica
|[[Entamoeba histolytica]]
|
|
* [[Abdominal cramps]]
* [[Abdominal cramps]]
Line 275: Line 274:
* Unintentional [[weight loss]]
* Unintentional [[weight loss]]
|cysts shed with the stool
|cysts shed with the stool
|detects ameba DNA in feces
|detects ameba [[DNA]] in feces
|Amebic dysentery ;
|[[Amebic dysentery]]
* [[Metronidazole]] 500-750mg three times a day for 5-10 days
* [[Metronidazole]] 500-750mg three times a day for 5-10 days
* [[Tinidazole]] 2g once a day for 3 days is an alternative to metronidazole
* [[Tinidazole]] 2g once a day for 3 days is an alternative to [[metronidazole]]
Luminal amebicides for ''[[E. histolytica]]'' in the colon:
Luminal amebicides for ''[[E. histolytica]]'' in the [[colon]]:
* [[Paromomycin]] 500mg three times a day for 10 days
* [[Paromomycin]] 500mg three times a day for 10 days
* [[Diloxanide furoate]] 500mg three times a day for 10 days
* [[Diloxanide furoate]] 500mg three times a day for 10 days
* [[Iodoquinol]] 650mg three times a day for 20 days
* [[Iodoquinol]] 650mg three times a day for 20 days
For amebic liver abscess:
For [[Amoebiasis|amebic liver abscess]]:
* [[Metronidazole]] 400mg three times a day for 10 days
* [[Metronidazole]] 400mg three times a day for 10 days
* [[Tinidazole]] 2g once a day for 6 days is an alternative to metronidazole
* [[Tinidazole]] 2g once a day for 6 days is an alternative to [[metronidazole]]
* [[Diloxanide furoate]] 500mg three times a day for 10 days must always be given afterwards.
* [[Diloxanide furoate]] 500mg three times a day for 10 days must always be given afterwards.
|}
|}

Revision as of 12:52, 26 July 2017

Chronic diarrhea Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic diarrhea from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

The differential diagnosis for chronic diarrhea is enormous, with a large number of diagnostic tests available that can be used to evaluate these patients. Classifying the patient with chronic diarrhea into a subcategory helps to direct the diagnostic work-up.

Differential diagnosis

The table below summarizes the findings that differentiate watery causes of chronic diarrhea

Cause Osmotic gap History Physical exam Gold standard Treatment
< 50 mOsm per kg > 50 mOsm per kg*
Watery Secretory Crohns + -
Hyperthyroidism + -
VIPoma + -
  • Elevated VIP levels
  • Followed by imaging
Osmotic Lactose intolerance - +
Celiac disease - +
Functional Irritable bowel syndrome - -

Abdominal pain or discomfort recurring at least 3 days per month in the past 3 months and associated with 2 or more of the following:

  • Onset associated with change in frequency of stool
  • Onset associated with change in appearance of stool

History of straining is also common

Template:WikiDoc Sources

The table below summarizes the findings that differentiate fatty causes of chronic diarrhea

Cause Osmotic gap History Physical exam Gold standard Treatment
< 50

mOsm

per kg

> 50

mOsm

per kg*

lactose intolerance - + Lactose breath hydrogen test Restriction of lactose and maintain calcium and vitamin D intake.
Celiac sprue - + Immunoglobulin A (IgA) anti-tissue transglutaminase (TTG) antibody followed by upper endoscopy with biopsy. Dietary counseling, elimination of gluten in the diet.
Whipple disease - + Upper endoscopy with biopsies of the small intestine for T. whipplei testing (histology with PAS staining, polymerase chain reaction [[[PCR]]] testing, and immunohistochemistry) Doxycycline and hydroxychloroquine are bactericidal

The table below summarizes the findings that differentiate inflammatory causes of chronic diarrhea

Cause History Laboratory findings Diagnosis Treatment
Diverticulitis Abdominal CT scan with oral and intravenous (IV) contrast bowel rest, IV fluid resuscitation, and broad-spectrum antimicrobial therapy which covers anaerobic bacteria and gram-negative rods
Ulcerative colitis Endoscopy Induction of remission with mesalamine and corticosteroids followed by the administration of sulfasalazine and 6-Mercaptopurine depending on the severity of the disease.
Entamoeba histolytica cysts shed with the stool detects ameba DNA in feces Amebic dysentery

Luminal amebicides for E. histolytica in the colon:

For amebic liver abscess:

References


Template:WH Template:WS